The Role of Dopamine in the Regulation of Sleep and Circadian Rhythms
Alterations in sleep/wakefulness behavior are among the most debilitating and highly prevalent non-motor symptoms of many neurological and psychiatric disorders that originate from perturbations of the Dopamine (DA) system. Curren...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
ASTROCLOCK
Astrocyte regulation of circadian behavior
242K€
Cerrado
BFU2013-43741-P
ESTUDIO EXPERIMENTAL Y CLINICO DE LA NARCOLEPSIA: MECANISMOS...
145K€
Cerrado
SAF2013-48532-R
MECANISMOS MOLECULARES RESPONSABLES DE LA PLASTICIDAD SINAPT...
399K€
Cerrado
BFU2010-20664
PAPEL DE DREAM EN LAS DISQUINESIAS Y EN LA PERDIDA DE NEURON...
315K€
Cerrado
PID2020-118511RB-I00
DINAMICA DE LOS AGREGADOS MACROMOLECULARES DE HETERORECEPTOR...
321K€
Cerrado
SAF2016-78207-R
BASES MOLECULARES DE LA PLASTICIDAD SINAPTICA ESTRIATAL EN L...
381K€
Cerrado
Información proyecto CircaDopamine
Duración del proyecto: 27 meses
Fecha Inicio: 2015-03-17
Fecha Fin: 2017-06-30
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Alterations in sleep/wakefulness behavior are among the most debilitating and highly prevalent non-motor symptoms of many neurological and psychiatric disorders that originate from perturbations of the Dopamine (DA) system. Currently, no effective therapeutic strategies are available to alleviate these symptoms. Inspired by my Ph.D results, the current proposal aims to investigate in detail the role of dopamine in the regulation of sleep and circadian rhythms. The main question under investigation is; By what mechanisms DA regulates sleep and circadian rhythms and how are these affected in diseases (such as Parkinson)? Two transgenic mouse models will be used; the first model (MitoPark) shows, like in Parkinson’s disease (PD) patients, a progressive age-dependent neurodegeneration of DA neurons. The second model (CircaDA) lacks functional clock gene oscillations selectively in DA neurons. Using polysomnography in MitoPark mice, a detailed investigation of the consequences of DA loss on sleep regulation will be performed. In-vivo multiunit electrophysiology will be used in both mouse models to study the role of the circadian changes in DA neurotransmission in driving and/or synchronizing the electrophysiological properties of striatal and cortical neurons. Finally, selective DA receptor drugs will be combined with in-vitro patch clamp electrophysiology and in-vitro Per2-bioluminescence to investigate the molecular pathways used by DA to modulate multiple electrophysiological correlates of clock gene oscillations. Collectively, this proposal holds promising fundamental and translational insights for sleep problems experienced by patients suffering from DA-related disorders and is expected to significantly contribute in fostering the academic career of the researcher and the competences of the hosting laboratory in Neurodegenerative diseases.